EPISODE · Mar 9, 2011 · 7 MIN
MBCC: Next Generation Treatment for Triple-Negative and Basal-Cell Breast Cancer
from Cancer Network Podcasts · host Cancer Network
The early promise of treating triple-negative and basal-cell breast cancers with poly (ADP-ribose) polymerase (PARP) inhibitors is yet to be realized, according to Lisa A. Carey, MD, who will be delivering a presentation on treatment options for these patients at the Miami Breast Cancer Conference this week.
Embed this episode
NOW PLAYING
MBCC: Next Generation Treatment for Triple-Negative and Basal-Cell Breast Cancer
0:00
7:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Cancer Network Podcasts?
This episode is 7 minutes long.
When was this Cancer Network Podcasts episode published?
This episode was published on March 9, 2011.
Can I download this Cancer Network Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!